PubMed COVID-19 Clinical Care
21851 - 21860 of 44979 results found
Transmission bottleneck size estimation from de novo viral genetic variation
Description
Sequencing of viral infections has become increasingly common over the last decade. Deep sequencing data in particular have proven useful in characterizing the roles that genetic drift and natural selection play in shaping within-host viral
The occurrence of acute primary angle closure triggered, aggravated, and accelerated by COVID-19 infection: retrospective observational study
Description
INTRODUCTION: The aim of this study is to demonstrate the relevance of primary acute angle closure (APAC) and COVID-19 infection, compare the demographic features and manifestations between COVID-19 positive and negative patients with APAC, and infer
The Relationship Between Risk Perception, Physical Activity, and Adolescent Mental Health: A Cross-Lagged Analysis
Description
CONCLUSION: This study underscores a longitudinal relationship between adolescents' perception of disease risk, physical activity, and mental health. It highlights the potential benefits of promoting physical activity awareness among adolescents as a
Barriers to infection prevention and control in long-term care/assisted living settings in British Columbia during the COVID-19 pandemic: a cross-sectional survey
Description
CONCLUSIONS: This survey found that barriers to HCWs' adherence to IPAC practices during the COVID-19 pandemic were different in LTC/AL settings compared to acute care. Improvement efforts should focus on strengthening IPAC programs in LTC/AL
Neutralization, effector function and immune imprinting of Omicron variants
Description
Currently circulating SARS-CoV-2 variants have acquired convergent mutations at hot spots in the receptor-binding domain¹ (RBD) of the spike protein. The effects of these mutations on viral infection and transmission and the efficacy of vaccines and
Characteristics of and Deaths among 333 Persons with Tuberculosis and COVID-19 in Cross-Sectional Sample from 25 Jurisdictions, United States
Description
Little is known about co-occurring tuberculosis (TB) and COVID-19 in low TB incidence settings. We obtained a cross-section of 333 persons in the United States co-diagnosed with TB and COVID-19 within 180 days and compared them to 4,433 persons with
Arbidol: The current demand, strategies, and antiviral mechanisms
Description
CONCLUSION: ARB is a broad-spectrum antiviral drug that inhibits several viruses in vivo and in vitro, with high safety profile and low resistance; the antiviral mechanisms of ARB deserve to be further explored and more high-quality clinical studies
